Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

"Abbott touts long-term efficacy for dissolvable Esprit BTK stent" was originally created and published by Medical Device ...

Media tour conducted in conjunction with D S Simon Media discussing Peripheral Artery Disease (PAD), one of the most prevalent diseases that no one has heard of, affecting one in 20 Americans over the ...

Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...

Gains from its Bitcoin holdings contributed notably to EPS growth. Semler Scientific produces the QuantaFlo -- a non-invasive ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds ...

Medical City Fort Worth has become the first hospital in North Texas to offer the percutaneous transmural arterial bypass ...

Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced the final 36-month ...

So if you have swelling due to any of those reasons, wearing compression socks throughout the day, including during exercise, ...

The data thus far suggest fewer repeat interventions with the newly FDA approved resorbable device compared with PTA.

Interventional cardiologist Dr. Ross Melvin joins us to give a demonstration of the new technology available to treat peripheral arterial disease.